BioNTech, Pfizer Sue CureVac on Covid Vaccine Patent Threats (1)

BioNTech SE and Pfizer Inc. asked a Massachusetts federal court to declare that their Covid-19 vaccine doesn’t infringe three patents held by CureVac NV, once a rival in the race to respond to the pandemic, according to a new lawsuit.

CureVac, which “has been unable to bring to market any product to help in the fight against Covid-19,” has threatened to file a “groundless” patent infringement suit in an attempt to profit from the BioNTech’s and Pfizer’s success, according to a complaint filed Monday in the US District Court for the District of Massachusetts.

The patents are related to ...